StockTipsArenaBeta

BUY Aster DM Healthcare Limited — ICICI Securities

BUYAster DM Healthcare Limited

byICICI SecuritiesHorizon: NA (inferred 1 year)21 Aug 2026via Institutional / Brokerage Research

Entry₹761.55Inferred
Target₹895
Total upside +17.52%
Stop lossNot given
CMP₹795.658h ago
Active+4.48%+12.49%upside left 12 mo left
Follow ICICI Securities for new calls(68% target hit, 1025 closed calls)Get alertsWatch ASTERDM for new buy/sell callsGet alertsSee 40 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Sept, 12:15 am IST
17 supporting12 neutral2 opposing
Supports the BUY call (17)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·7 Sept · today

Aster DM founder Azad Moopen’s family raises stake to 24.58% with ₹350-crore share purchase

NewsCnbc-Tv18·4 Sept · 3d ago

(opens in new tab)

Dr. Moopen family has acquired additional shares in Aster DM Quality Care Ltd, indicating increased confidence and investment from a key stakeholder.

BSE · Company Update·4 Sept · 3d ago

(opens in new tab)

A subsidiary of Aster DM Quality Care Ltd has acquired equity shares of STS Holdings Limited. This acquisition is a strategic move for the company's growth.

BSE · Company Update·28 Aug · 1w ago

(opens in new tab)
Neutral / worth noting (12)

Aster DM Quality Care Ltd's step-down subsidiaries, KIMSHEALTH Executive Leisure Private Limited and Spiceretreat Hospitality Services Private Limited, have approved a scheme of amalgamation. The appo

BSE · Company Update·29 Aug · 1w ago

(opens in new tab)

Aster DM Quality Care Block Deal: Shares worth nearly ₹7,800 crore change hands

NewsCnbc-Tv18·19 Aug · 3w ago

(opens in new tab)

Aster DM Healthcare: 35.35 Billion Shares Approved for Trading Post-Amalgamation

NewsGoogle News·14 Aug · 3w ago

(opens in new tab)
Weighs against the BUY call (2)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.